The method, called KMAP, enables intuitive visualization of short DNA sequences and helps reveal how regulatory elements behave in different biological contexts. The study was recently published ...

To reduce the risks of drug development, KaiPharm, based in Seoul, South Korea, has developed KMAP, which combines artificial intelligence (AI) with transcriptome profiling to generate deep ...

Researchers from the University of Eastern Finland, Aalto University and the University of Oulu have developed a new ...